Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Standard BioTools Inc. (LAB) had Return on Tangible Equity of -13.86% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$85.33M
Net Income	$-74.90M
Cost of Goods Sold	$42.79M
Gross Profit	$42.54M
Operating Expenses	$195.58M
Operating Income	$-110.25M
Non-Operating Income/Expense	$13.55M
Pre-Tax Income	$-96.70M
Normalized Pre-Tax Income	$-96.70M
Income after Taxes	$-58.83M
Income from Continuous Operations	$-58.83M
Consolidated Net Income/Loss	$-74.90M
Normalized Income after Taxes	$-58.83M
EBIT	$-110.25M
EBITDA	$-101.92M
Weighted-Average Shares Outstanding (Basic)	381.62M
Weighted-Average Shares Outstanding (Diluted)	381.62M
Earnings per Share (EPS) (Basic)	$-0.20
Earnings per Share (EPS) (Diluted)	$-0.20
Balance Sheet Financials
Current Assets	$454.26M
Property, Plant, and Equipment	$19.27M
Long-Term Assets	$113.49M
Total Assets	$567.75M
Current Liabilities	$108.31M
Long-Term Debt	$0.30M
Long-Term Liabilities	$35.16M
Total Liabilities	$143.46M
Common Equity	$424.29M
Tangible Shareholders Equity	$424.29M
Shareholders Equity	$424.29M
Common Shares Outstanding	386.38M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-74.34M
Cash Flow from Investing Activities	$27.41M
Cash Flow from Financial Activities	$0.57M
Beginning Cash	$168.82M
End Cash	$123.30M
Increase/Decrease in Cash	$-45.52M
Stock-Based Compensation	$29.61M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.19
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.00
Debt to Equity Ratio	0.00
Gross Margin	49.86%
Operating Margin	-129.20%
EBIT Margin	-129.20%
EBITDA Margin	-119.44%
Pre-Tax Profit Margin	-113.33%
Profit Margin	-87.77%
Free Cash Flow	$-82.65M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	2.14
Receiveable Turnover	6.35
Days Sales in Receivables	57.45
Return on Equity	-13.86%
Return on Tangible Equity	-13.86%
Return on Assets	-10.36%
Return on Investments	-13.85%
Book Value Per Share	$1.10
Free Cash Flow per Share	$-0.22
Operating Cash Flow per Share	$-0.19

Data from Zacks Investment Research, Inc.